More Island Pharmaceuticals Ltd news
Island Pharmaceuticals LtdASX: ILA

US FDA Type C meeting briefing document submitted

Sep 29, 2025 at 2:50 AM UTC

Island Pharmaceuticals Ltd has released a press release.

View Attachment